HomeHLS • TSE
add
HLS Therapeutics Inc
Previous close
$5.70
Day range
$5.59 - $5.75
Year range
$3.00 - $5.75
Market cap
175.28M CAD
Avg Volume
11.10K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 14.17M | -2.40% |
Operating expense | 11.08M | -13.59% |
Net income | -2.74M | 51.76% |
Net profit margin | -19.34 | 50.58% |
Earnings per share | -0.09 | 68.59% |
EBITDA | 4.70M | 22.81% |
Effective tax rate | -9.68% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.15M | -62.62% |
Total assets | 149.07M | -22.08% |
Total liabilities | 82.51M | -24.03% |
Total equity | 66.56M | — |
Shares outstanding | 31.39M | — |
Price to book | 2.70 | — |
Return on assets | -1.28% | — |
Return on capital | -1.54% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.74M | 51.76% |
Cash from operations | 4.60M | 82.77% |
Cash from investing | -1.09M | -108.20% |
Cash from financing | -9.46M | -266.86% |
Net change in cash | -5.58M | -142.69% |
Free cash flow | 5.04M | -71.24% |
About
Founded
2014
Website
Employees
85
